GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (XBRU:ARGX) » Definitions » Median PS Value

argenx SE (XBRU:ARGX) Median PS Value : €1,132.11 (As of Dec. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is argenx SE Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. argenx SE's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €27.841. argenx SE's 10-Year median PS Ratio is 40.6634. Therefore, the Median PS Value for today is €1,132.11.

As of today (2024-12-15), argenx SE's share price is €580.80. argenx SE's Median PS Value is €1,132.11. Therefore, argenx SE's Price to Median PS Value for today is 0.51.

The historical rank and industry rank for argenx SE's Median PS Value or its related term are showing as below:

XBRU:ARGX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.37   Med: 0.38   Max: 0.52
Current: 0.51

During the past 13 years, the highest Price to Median PS Value of argenx SE was 0.52. The lowest was 0.37. And the median was 0.38.

XBRU:ARGX's Price-to-Median-PS-Value is ranked better than
67.05% of 264 companies
in the Biotechnology industry
Industry Median: 0.7 vs XBRU:ARGX: 0.51

argenx SE Median PS Value Historical Data

The historical data trend for argenx SE's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Median PS Value Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

argenx SE Quarterly Data
Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 981.16 1,073.24 1,132.11

Competitive Comparison of argenx SE's Median PS Value

For the Biotechnology subindustry, argenx SE's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where argenx SE's Price-to-Median-PS-Value falls into.



argenx SE Median PS Value Calculation

argenx SE's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=27.841*40.6634
=1,132.11

10-Year Median PS Ratio is 40.6634.
argenx SE's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €27.841.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE  (XBRU:ARGX) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

argenx SE's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=580.80/1,132.11
=0.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


argenx SE Median PS Value Related Terms

Thank you for viewing the detailed overview of argenx SE's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.